sábado, 16 de noviembre de 2019

A drug maker courted controversy when it shut out a family-run rival. Now some patients say the medicine isn’t working By ED SILVERMAN

https://www.statnews.com/pharmalot/2019/11/15/a-drug-maker-courted-controversy-when-it-shut-out-a-family-run-rival-now-some-patients-say-the-medicine-isnt-working/?utm_source=STAT+Newsletters&utm_campaign=416cfc7254-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-416cfc7254-149692869
Daily Recap

A drug maker courted controversy when it shut out a family-run rival. Now some patients say the medicine isn’t working

By ED SILVERMAN

ADOBE
Over the past few months, about 30 people who suffer from Lambert-Eaton myasthenic syndrome, or LEMS, have switched back to an older treatment.

No hay comentarios: